Loading: 100%
QUEST DIAGNOSTICS INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Madison, United States of AmericaMadison, United States of Americano data available
Employees 43,000 (as per Q1 2017)no data available
Sector Medical Diagnostics & Research, HealthcareMedical Diagnostics & Research, Healthcareno data available
Ticker DGXno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 17708090100110
datesClosing price (adj.)
13.10.201791.06
11.10.201791.45
04.10.201792.96
27.09.201792.64
20.09.2017101.31
13.09.2017106.38
06.09.2017106.75
30.08.2017106.75
23.08.2017106.23
16.08.2017106.24
09.08.2017105.99
02.08.2017107.45
26.07.2017107.70
19.07.2017109.40
12.07.2017108.38
05.07.2017109.81
27.06.2017108.50
20.06.2017107.38
13.06.2017107.47
06.06.2017108.17
30.05.2017106.93
23.05.2017105.56
16.05.2017105.45
09.05.2017106.33
02.05.2017105.85
25.04.2017104.97
18.04.201796.25
11.04.201797.36
04.04.201796.75
28.03.201797.51
21.03.201797.11
14.03.201797.34
07.03.201796.85
28.02.201796.13
21.02.201794.58
14.02.201793.34
07.02.201791.38
31.01.201790.69
24.01.201790.12
17.01.201791.02
10.01.201791.75
03.01.201790.77
27.12.201690.83
19.12.201690.70
12.12.201690.04
05.12.201686.71
28.11.201686.62
21.11.201685.70
14.11.201683.55
07.11.201680.97
31.10.201679.96
24.10.201682.15
17.10.201681.53
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
91.06n/a
Market Capitalisation
in million USD
12,459n/a
Enterprise Value
in million USD
15,982n/a
Common Shares Outstanding
as per Apr 13, 2017
136,825,521n/a
Preferred Shares Outstanding
as per Apr 13, 2017
n/a
Average Basic Shares Outstanding
TTM
138,500,000n/a
Average Diluted Shares Outstanding
TTM
141,250,000n/a
Index Membership
n/a
Business Summary
Quest Diagnostics Inc provides diagnostic testing, information, and services, providing insights that enable patients and physicians to make healthcare decisions. It provides diagnostics for insurers and healthcare information technology businesses.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 7,503n/a
Gross Profit 2,897n/a
Operating Income 1,122n/a
EBITDA 0n/a
Net Profit 678n/a
Balance Sheet
Cash and Cash Equivalents 406n/a
Receivables 966n/a
Total Current Assets 1,642n/a
PP&E 952n/a
Total Assets 10,173n/a
Accounts Payable 1,039n/a
Current Debt 7n/a
Total Current Liabilities 1,046n/a
Long-Term Debt 3,815n/a
Total Liabilities 5,403n/a
Total Equity 4,770n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 38.6%n/a
Operating Margin 15.0%n/a
Net Profit Margin 9.7%n/a
Return on Equity 15.3%n/a
Return on Assets 7.2%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 2.13n/a
Book to Market Value 0.38n/a
Other Ratios
Current Ratio 157.0%n/a
Liabilities to Equity Ratio 113.3%n/a
Debt to Assets Ratio 37.6%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
6,705
7,249
7,455
7,260
7,392
7,383
7,146
7,435
7,493
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-3,970
-4,256
-4,321
-4,276
-4,363
-4,365
-4,326
-4,637
-4,657
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
2,735
2,993
3,134
2,985
3,029
3,018
2,820
2,798
2,836
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-1,644
-1,771
-1,775
-1,701
-2,042
-1,817
-1,819
-1,815
-1,771
Selling, General & Administrative
-1,613
-1,737
-1,748
-1,659
-1,743
-1,745
-1,704
-1,728
-1,679
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
-28
-37
-37
-33
-61
-75
-79
-94
-81
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
-3
3
10
-9
-238
3
-36
7
-11
Operating Income (Loss)
1,091
1,222
1,359
1,284
987
1,201
1,001
983
1,065
Non-Operating Income (Loss)
-179
-201
-164
-138
-167
-159
-151
-160
-296
Interest Expense, net
-178
-180
-144
-143
-170
-165
-159
-164
-153
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
-1
-22
-20
5
3
6
8
4
-143
Pretax Income (Loss), Adjusted
912
1,021
1,195
1,145
820
1,042
850
823
769
Abnormal Gains (Losses)
0
0
0
0
0
0
474
0
334
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
912
1,021
1,195
1,145
820
1,042
1,324
823
1,103
Income Tax (Expense) Benefit, net
-359
-387
-460
-430
-355
-402
-500
-262
-373
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
27
30
33
30
29
26
24
26
23
Income (Loss) from Continuing Operations
580
664
767
745
494
666
848
587
753
Net Extraordinary Gains (Losses)
-214
-51
-1
12
12
-74
35
5
0
Discontinued Operations
-214
-51
-1
12
12
-74
35
5
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
366
613
766
757
506
592
883
592
753
Minority Interest
-27
-32
-37
-36
-35
-36
-34
-36
-44
Net Income
340
581
729
721
471
556
849
556
709
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
340
581
729
721
471
556
849
556
709
Remarks
restated on Feb 17, 2010 n/a
calculated values,
restated on Feb 16, 2011 n/a
calculated values,
restated on Feb 16, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 18, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
254
534
449
165
296
187
192
133
Cash & Cash Equivalents
n/a
254
534
449
165
296
187
192
133
Short Term Investments
n/a
0
0
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
833
827
845
906
867
852
932
901
Accounts Receivable, Net
n/a
833
827
845
906
867
852
932
901
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
102
91
77
89
93
91
110
84
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
308
226
234
241
305
253
369
383
Prepaid Expenses
n/a
89
95
92
87
91
105
186
207
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
40
0
14
176
Deferred Tax Assets
n/a
218
132
142
153
174
148
169
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
0
0
0
0
0
Total Current Assets
n/a
1,497
1,679
1,605
1,401
1,561
1,383
1,603
1,501
Property, Plant & Equipment, Net
n/a
880
826
834
800
756
805
933
925
Property, Plant & Equipment
n/a
0
0
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
46
473
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
6,027
6,058
6,088
7,112
6,967
6,760
7,275
7,063
Intangible Assets
n/a
827
824
796
1,036
872
896
1,071
984
Goodwill
n/a
5,055
5,084
5,102
5,796
5,536
5,649
6,032
5,905
Other Intangible Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
145
151
189
281
559
215
172
174
Total Noncurrent Assets
n/a
6,907
6,884
6,922
7,912
7,723
7,565
8,254
8,461
Total Assets
n/a
8,404
8,564
8,528
9,313
9,284
8,948
9,857
9,962
Liabilities and owners' equity
Payables & Accruals
n/a
1,220 1219619000
889 888705000
865 865272000
907 906764000
1,016 1016000000
920 920000000
1,191 1191000000
1,014 1014000000
Accounts Payable
n/a
1,220 1219619000
889 888705000
865 865272000
907 906764000
1,016 1016000000
920 920000000
1,191 1191000000
1,014 1014000000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
5 5142000
171 170507000
349 348996000
654 654395000
10 10000000
212 212000000
518 518000000
159 159000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
22 22000000
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
22 22000000
0 0
0 0
0 0
Total Current Liabilities
n/a
1,225 1224761000
1,059 1059212000
1,214 1214268000
1,561 1561159000
1,048 1048000000
1,132 1132000000
1,709 1709000000
1,173 1173000000
Long Term Debt
n/a
3,078 3078089000
2,937 2936792000
2,641 2641160000
3,371 3370522000
3,354 3354000000
3,120 3120000000
3,224 3224000000
3,492 3492000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
476 475846000
556 556175000
618 618077000
667 666699000
696 696000000
723 723000000
594 594000000
514 514000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
476 475846000
556 556175000
618 618077000
667 666699000
696 696000000
723 723000000
594 594000000
514 514000000
Total Noncurrent Liabilities
n/a
3,554 3553935000
3,493 3492967000
3,259 3259237000
4,037 4037221000
4,050 4050000000
3,843 3843000000
3,818 3818000000
4,006 4006000000
Total Liabilities
n/a
4,779 4778696000
4,552 4552179000
4,474 4473505000
5,598 5598380000
5,098 5098000000
4,975 4975000000
5,527 5527000000
5,179 5179000000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
2,264 2264206000
2,305 2304509000
2,314 2313563000
2,350 2349664000
2,373 2373000000
2,381 2381000000
2,420 2420000000
2,483 2483000000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-1,153 -1152921000
-1,511 -1510548000
-2,158 -2158129000
-2,912 -2912324000
-2,914 -2914000000
-3,783 -3783000000
-3,815 -3815000000
-3,960 -3960000000
Retained Earnings
n/a
2,562 2561679000
3,217 3216639000
3,867 3867420000
4,264 4263599000
4,690 4690000000
5,358 5358000000
5,723 5723000000
6,199 6199000000
Other Equity
n/a
-68 -68068000
-21 -20961000
11 10626000
-8 -8067000
14 14000000
-8 -8000000
-27 -27000000
-38 -38000000
Equity Before Minority Interest
n/a
3,605 3604896000
3,990 3989639000
4,033 4033480000
3,693 3692872000
4,163 4163000000
3,948 3948000000
4,301 4301000000
4,684 4684000000
Minority Interest
n/a
20 20238000
22 21825000
21 20645000
22 22127000
23 23000000
25 25000000
29 29000000
99 99000000
Total Equity
n/a
3,625 3625134000
4,011 4011464000
4,054 4054125000
3,715 3714999000
4,186 4186000000
3,973 3973000000
4,330 4330000000
4,783 4783000000
Total Liabilities & Equity
n/a
8,404 8403830000
8,564 8563643000
8,528 8527630000
9,313 9313379000
9,284 9284000000
8,948 8948000000
9,857 9857000000
9,962 9962000000
Remarks restated on n/a restated on Feb 17, 2010 n/a restated on Feb 16, 2011 n/a restated on Feb 16, 2012 n/a restated on Feb 27, 2013 n/a restated on Feb 18, 2014 n/a restated on Feb 24, 2015 n/a restated on Feb 26, 2016 n/a restated on Feb 22, 2017 n/a
Cash Flow StatementCF data quality: 91% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
366
613
766
757
506
592
883
592
753
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
238
265
257
254
281
287
283
314
304
Non-Cash Items
575
481
189
349
380
472
-142
358
128
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
-252
-296
-214
-242
-272
-164
-372
-326
-375
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
927
1,063
997
1,118
895
1,187
652
938
810
Change in Fixed Assets & Intangibles
-219
-213
-167
-205
-161
-182
-231
-308
-263
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
214
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-1,536
8
-18
0
-1,299
-51
557
-728
-100
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-4
6
-11
-11
3
16
2
11
1
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-1,759
-199
-196
-217
-1,243
-217
328
-1,025
-362
Dividends Paid
-77
-78
-75
-71
-65
-108
-185
-187
-212
Cash From (Repayment of) Debt
1,024
-459
27
-169
979
-654
-4
371
-84
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-65
-223
-413
-701
-798
-38
-899
-54
-164
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
-32
-17
-61
-44
-52
-22
-18
-38
-47
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
850
-778
-521
-986
64
-822
-1,106
92
-507
Net Cash Before Disc. Operations and FX
18
86
280
-85
-284
148
-126
5
-59
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
18
86
280
-85
-284
148
-126
5
-59
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
Net Changes in Cash
18
86
280
-85
-284
148
-126
5
-59
Remarks
restated on Feb 17, 2010 n/a
calculated values,
restated on Feb 16, 2011 n/a
calculated values,
restated on Feb 16, 2012 n/a
calculated values,
restated on Feb 27, 2013 n/a
calculated values,
restated on Feb 18, 2014 n/a
calculated values,
restated on Feb 24, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
restated on Feb 22, 2017 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo